Estimating time-to-onset of adverse drug reactions from spontaneous reporting databases

BACKGROUND: Analyzing time-to-onset of adverse drug reactions from treatment exposure contributes to meeting pharmacovigilance objectives, i.e. identification and prevention. Post-marketing data are available from reporting systems. Times-to-onset from such databases are right-truncated because some...

Descripción completa

Detalles Bibliográficos
Autores principales: Leroy, Fanny, Dauxois, Jean-Yves, Théophile, Hélène, Haramburu, Françoise, Tubert-Bitter, Pascale
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3923259/
https://www.ncbi.nlm.nih.gov/pubmed/24490673
http://dx.doi.org/10.1186/1471-2288-14-17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3923259/
https://www.ncbi.nlm.nih.gov/pubmed/24490673
http://dx.doi.org/10.1186/1471-2288-14-17

Ejemplares similares